Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up 0.91% Nasdaq Up 0.87%
Streaming
Ticker Tape: On

CytRx Corporation (CYTR)

-NasdaqCM

2.14 Up 0.01(0.47%) 4:00PM EDT

Add to Portfolio
Prev Close:2.13
Open:2.17
Bid:1.80 x 300
Ask:N/A
1y Target Est:8.50
Beta:1.59
Next Earnings Date:N/A
Day's Range:2.11 - 2.17
52wk Range:1.59 - 5.50
Volume:42,268
Avg Vol (3m):115,264
Market Cap:65.31M
P/E (ttm):N/A
EPS (ttm):-0.58
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CYTR

Reports

Comparison

Symbol% ChgMkt Cap
CYTRUp 0.47%65.31M
RHHBYN.MXUp 1.64%2.74T
SHP.LDown 0.38%11.51B
SUNPHARMA.NSDown 0.08%1.00T
GILD.MXUp 2.37%1.02T

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):650.01
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-13) :-0.81
Quarterly EPS Est (Jun-13) :-0.20
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

CytRx Corporation is a biopharmaceutical research and development company specializing in oncology. Its oncology pipeline includes two programs, aldoxorubicin and tamibarotene, which are in clinical development for cancer indications. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback